Panel Endorses FDA Compromise On Uterine Embolization Trial Enrollment

Clinical trials of uterine fibroid embolization (UFE) techniques may include women taking hormonal contraceptives, provided data is stratified during analysis, FDA's Obstetrics and Gynecology Devices Panel suggested May 22 at a meeting in Gaithersburg, Maryland.

More from Archive

More from Medtech Insight